| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Radius Health Inc (NASDAQ: RDUS)
RDUS Technical Analysis
4
| As on 8th May 2025 RDUS STOCK Price closed @ 29.38 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 20.03 & Buy for SHORT-TERM with Stoploss of 27.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RDUSSTOCK Price
| Open | 29.41 | Change | Price | % |
| High | 29.42 | 1 Day | 0.03 | 0.10 |
| Low | 29.31 | 1 Week | -0.06 | -0.20 |
| Close | 29.38 | 1 Month | 0.28 | 0.96 |
| Volume | 915487 | 1 Year | 4.95 | 20.26 |
| 52 Week High 31.61 | 52 Week Low 10.96 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| DGLY | 0.06 | 20.00% |
| GNLN | 0.01 | 0.00% |
| NVDA | 117.37 | 0.26% |
| LMDX | 0.02 | 0.00% |
| PLUG | 0.85 | 8.97% |
| AKTS | 0.04 | 0.00% |
| TSLA | 284.82 | 3.11% |
| ZKIN | 2.52 | 123.01% |
| VEEE | 7.45 | 192.16% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RDUS Daily Charts |
RDUS Intraday Charts |
Whats New @ Bazaartrend |
RDUS Free Analysis |
|
|
RDUS Important Levels Intraday
| RESISTANCE | 29.59 |
| RESISTANCE | 29.52 |
| RESISTANCE | 29.48 |
| RESISTANCE | 29.44 |
| SUPPORT | 29.32 |
| SUPPORT | 29.28 |
| SUPPORT | 29.24 |
| SUPPORT | 29.17 |
RDUS Forecast May 2025
| 4th UP Forecast | 42.35 |
| 3rd UP Forecast | 38.19 |
| 2nd UP Forecast | 35.62 |
| 1st UP Forecast | 33.05 |
| 1st DOWN Forecast | 25.71 |
| 2nd DOWN Forecast | 23.14 |
| 3rd DOWN Forecast | 20.57 |
| 4th DOWN Forecast | 16.41 |
RDUS Weekly Forecast
| 4th UP Forecast | 33.10 |
| 3rd UP Forecast | 31.91 |
| 2nd UP Forecast | 31.17 |
| 1st UP Forecast | 30.43 |
| 1st DOWN Forecast | 28.33 |
| 2nd DOWN Forecast | 27.59 |
| 3rd DOWN Forecast | 26.85 |
| 4th DOWN Forecast | 25.66 |
RDUS Forecast2025
| 4th UP Forecast | 70.1 |
| 3rd UP Forecast | 57.04 |
| 2nd UP Forecast | 48.97 |
| 1st UP Forecast | 40.9 |
| 1st DOWN Forecast | 17.86 |
| 2nd DOWN Forecast | 9.79 |
| 3rd DOWN Forecast | 1.72 |
| 4th DOWN Forecast | -11.34 |
Radius Health Inc ( NASDAQ USA Symbol : RDUS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RDUS Business Profile
Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. Address: 22 Boston Wharf Road, Boston, MA, United States, 02210
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service